The Oncosearch | Oncotarget

Inhibition of EZH2 triggers the tumor suppressive miR-29b network in multiple myeloma Research Paper

Maria Angelica Stamato, Giada Juli, Enrica Romeo, Domenica Ronchetti, Mariamena Arbitrio, Daniele Caracciolo, Antonino Neri, Pierosandro Tagliaferri, Pierfrancesco Tassone, Nicola Amodio

Published Nov 20, 2017 · Vol. 8, No. 63 · pp. 106527-106537

Transient paraproteinemia after allogeneic hematopoietic stem cell transplantation is an underexplored phenomenon associated with graft versus host disease Research Paper

Corinne C. Widmer, Stefan Balabanov, Urs Schanz, Alexandre P.A. Theocharides

Published Nov 15, 2017 · Vol. 8, No. 63 · pp. 106333-106341

Prognostic value of diametrically polarized tumor-associated macrophages in multiple myeloma Research Paper

Xinyi Chen, Jin Chen, Wenyan Zhang, Ruixue Sun, Ting Liu, Yuhuan Zheng, Yu Wu

Published Nov 9, 2017 · Vol. 8, No. 68 · pp. 112685-112696

Trends and variations in mantle cell lymphoma incidence from 1995 to 2013: A comparative study between Texas and National SEER areas Research Paper

Shuangshuang Fu, Michael Wang, David R. Lairson, Ruosha Li, Bo Zhao, Xianglin L. Du

Published Nov 3, 2017 · Vol. 8, No. 68 · pp. 112516-112529

The cancer-testis antigen, sperm protein 17, a new biomarker and immunological target in head and neck squamous cell carcinoma Research Paper

Christopher A. Schutt, Leonardo Mirandola, Jose A. Figueroa, Diane D. Nguyen, Joehassin Cordero, Klauss Bumm, Benjamin L. Judson, Maurizio Chiriva-Internati

Published Oct 31, 2017 · Vol. 8, No. 59 · pp. 100280-100287

CD24, CD27, CD36 and CD302 gene expression for outcome prediction in patients with multiple myeloma Research Paper

Elina Alaterre, Sebastien Raimbault, Hartmut Goldschmidt, Salahedine Bouhya, Guilhem Requirand, Nicolas Robert, StÃ©phanie Boireau, Anja Seckinger, Dirk Hose, Bernard Klein, JÃ©rÃ´me Moreaux

Published Oct 30, 2017 · Vol. 8, No. 58 · pp. 98931-98944

LncRNA MALAT1 acts as an oncogene in multiple myeloma through sponging miR-509-5p to modulate FOXP1 expression Research Paper

Yueli Gu, Xichun Xiao, Shuo Yang

Published Oct 23, 2017 · Vol. 8, No. 60 · pp. 101984-101993

VS-5584 mediates potent anti-myeloma activity via the upregulation of a class II tumor suppressor gene, RARRES3 and the activation of Bim Research Paper

Nurulhuda Mustafa, Jeannie Xue Ting Lee, Huey Fang Adina Nee, Chonglei Bi, Tae-Hoon Chung, Stefan Hart, Wee Joo Chng

Published Oct 20, 2017 · Vol. 8, No. 60 · pp. 101847-101864

The polycomb group protein BMI-1 inhibitor PTC-209 is a potent anti-myeloma agent alone or in combination with epigenetic inhibitors targeting EZH2 and the BET bromodomains Research Paper

Mohammad Alzrigat, Alba Atienza PÃ¡rraga, Muntasir Mamun Majumder, Anqi Ma, Jian Jin, Anders Ã–sterborg, Hareth Nahi, Kenneth Nilsson, Caroline A. Heckman, Fredrik Ã–berg, Antonia Kalushkova, Helena Jernberg-Wiklund

Published Oct 20, 2017 · Vol. 8, No. 61 · pp. 103731-103743

Bone marrow fibrosis in chronic myelomonocytic leukemia is associated with increased megakaryopoiesis, splenomegaly and with a shorter median time to disease progression Research Paper

Kseniya Petrova-Drus, April Chiu, Elizabeth Margolskee, Sharon Barouk-Fox, Julia Geyer, Ahmet Dogan, Attilio Orazi

Published Oct 17, 2017 · Vol. 8, No. 61 · pp. 103274-103282

Autologous transplant for myeloma: when the old meets the new Editorial

Francesca Gay, Mariella Genuardi, Mario Boccadoro

Published Oct 8, 2017 · Vol. 8, No. 53 · pp. 90618-90619

Circulating tumour DNA analysis in multiple myeloma Editorial

Sridurga Mithraprabhu, Andrew Spencer

Published Oct 7, 2017 · Vol. 8, No. 53 · pp. 90610-90611

Interleukin-32α promotes the proliferation of multiple myeloma cells by inducing production of IL-6 in bone marrow stromal cells Research Paper

Xuanru Lin, Li Yang, Gang Wang, Fuming Zi, Haimeng Yan, Xing Guo, Jing Chen, Qingxiao Chen, Xi Huang, Yi Li, Enfan Zhang, Wenjun Wu, Yang Yang, Donghua He, Jingsong He, Zhen Cai

Published Oct 7, 2017 · Vol. 8, No. 54 · pp. 92841-92854

Antitumor activity of a newly developed monoclonal antibody against ROR1 in ovarian cancer cells Research Paper

Zhengna Yin, Mengyun Gao, Sasa Chu, Yiping Su, Chunping Ye, Yiquan Wang, Zhuanqin Pan, Zhuming Wang, Huilin Zhang, Hua Tong, Jin Zhu

Published Oct 7, 2017 · Vol. 8, No. 55 · pp. 94210-94222

Lenalidomide overcomes the immunosuppression of regulatory CD8⁺CD28^â€“ T-cells Research Paper

Brigitte Neuber, Jingying Dai, Wjahat A. Waraich, Mohamed H.S. Awwad, Melanie Engelhardt, Michael Schmitt, Sergej Medenhoff, Mathias Witzens-Harig, Anthony D. Ho, Hartmut Goldschmidt, Michael Hundemer

Published Oct 5, 2017 · Vol. 8, No. 58 · pp. 98200-98214

Hyperhaploid karyotypes in multiple myeloma Editorial

Jeffrey R. Sawyer, Gareth J. Morgan

Published Sep 14, 2017 · Vol. 8, No. 45 · pp. 78259-78260

Chromosomal instability and acquired drug resistance in multiple myeloma Review

Wang Wang, Yi Zhang, Ruini Chen, Zhidan Tian, Yongpin Zhai, Siegfried Janz, Chunyan Gu, Ye Yang

Published Sep 11, 2017 · Vol. 8, No. 44 · pp. 78234-78244

A novel Fc-engineered human ICAM-1/CD54 antibody with potent anti-myeloma activity developed by cellular panning of phage display libraries Research Paper

Katja Klausz, Michael Cieker, Christian Kellner, Hans-Heinrich Oberg, Dieter Kabelitz, Thomas Valerius, Renate Burger, Martin Gramatzki, Matthias Peipp

Published Sep 5, 2017 · Vol. 8, No. 44 · pp. 77552-77566

Chondroitin sulfate proteoglycan serglycin influences protein cargo loading and functions of tumor-derived exosomes Research Paper

Anurag Purushothaman, Shyam K. Bandari, Darshan S. Chandrashekar, Richard J. Jones, Hans C. Lee, Donna M. Weber, Robert Z. Orlowski

Published Aug 27, 2017 · Vol. 8, No. 43 · pp. 73723-73732

Glutaminase inhibition in multiple myeloma induces apoptosis via MYC degradation Research Paper

Madlen Effenberger, Kathryn S. Bommert, Viktoria Kunz, Jessica Kruk, Ellen Leich, Martina Rudelius, Ralf Bargou, Kurt Bommert

Published Aug 24, 2017 · Vol. 8, No. 49 · pp. 85858-85867

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Inhibition of EZH2 triggers the tumor suppressive miR-29b network in multiple myeloma Research Paper

Transient paraproteinemia after allogeneic hematopoietic stem cell transplantation is an underexplored phenomenon associated with graft versus host disease Research Paper

Prognostic value of diametrically polarized tumor-associated macrophages in multiple myeloma Research Paper

Trends and variations in mantle cell lymphoma incidence from 1995 to 2013: A comparative study between Texas and National SEER areas Research Paper

The cancer-testis antigen, sperm protein 17, a new biomarker and immunological target in head and neck squamous cell carcinoma Research Paper

CD24, CD27, CD36 and CD302 gene expression for outcome prediction in patients with multiple myeloma Research Paper

LncRNA MALAT1 acts as an oncogene in multiple myeloma through sponging miR-509-5p to modulate FOXP1 expression Research Paper

VS-5584 mediates potent anti-myeloma activity via the upregulation of a class II tumor suppressor gene, RARRES3 and the activation of Bim Research Paper

The polycomb group protein BMI-1 inhibitor PTC-209 is a potent anti-myeloma agent alone or in combination with epigenetic inhibitors targeting EZH2 and the BET bromodomains Research Paper

Bone marrow fibrosis in chronic myelomonocytic leukemia is associated with increased megakaryopoiesis, splenomegaly and with a shorter median time to disease progression Research Paper

Autologous transplant for myeloma: when the old meets the new Editorial

Circulating tumour DNA analysis in multiple myeloma Editorial

Interleukin-32α promotes the proliferation of multiple myeloma cells by inducing production of IL-6 in bone marrow stromal cells Research Paper

Antitumor activity of a newly developed monoclonal antibody against ROR1 in ovarian cancer cells Research Paper

Lenalidomide overcomes the immunosuppression of regulatory CD8⁺CD28^â€“ T-cells Research Paper

Hyperhaploid karyotypes in multiple myeloma Editorial

Chromosomal instability and acquired drug resistance in multiple myeloma Review

A novel Fc-engineered human ICAM-1/CD54 antibody with potent anti-myeloma activity developed by cellular panning of phage display libraries Research Paper

Chondroitin sulfate proteoglycan serglycin influences protein cargo loading and functions of tumor-derived exosomes Research Paper

Glutaminase inhibition in multiple myeloma induces apoptosis via MYC degradation Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Inhibition of EZH2 triggers the tumor suppressive miR-29b network in multiple myeloma Research Paper

Transient paraproteinemia after allogeneic hematopoietic stem cell transplantation is an underexplored phenomenon associated with graft versus host disease Research Paper

Prognostic value of diametrically polarized tumor-associated macrophages in multiple myeloma Research Paper

Trends and variations in mantle cell lymphoma incidence from 1995 to 2013: A comparative study between Texas and National SEER areas Research Paper

The cancer-testis antigen, sperm protein 17, a new biomarker and immunological target in head and neck squamous cell carcinoma Research Paper

CD24, CD27, CD36 and CD302 gene expression for outcome prediction in patients with multiple myeloma Research Paper

LncRNA MALAT1 acts as an oncogene in multiple myeloma through sponging miR-509-5p to modulate FOXP1 expression Research Paper

VS-5584 mediates potent anti-myeloma activity via the upregulation of a class II tumor suppressor gene, RARRES3 and the activation of Bim Research Paper

The polycomb group protein BMI-1 inhibitor PTC-209 is a potent anti-myeloma agent alone or in combination with epigenetic inhibitors targeting EZH2 and the BET bromodomains Research Paper

Bone marrow fibrosis in chronic myelomonocytic leukemia is associated with increased megakaryopoiesis, splenomegaly and with a shorter median time to disease progression Research Paper

Autologous transplant for myeloma: when the old meets the new Editorial

Circulating tumour DNA analysis in multiple myeloma Editorial

Interleukin-32α promotes the proliferation of multiple myeloma cells by inducing production of IL-6 in bone marrow stromal cells Research Paper

Antitumor activity of a newly developed monoclonal antibody against ROR1 in ovarian cancer cells Research Paper

Lenalidomide overcomes the immunosuppression of regulatory CD8+CD28â€“ T-cells Research Paper

Hyperhaploid karyotypes in multiple myeloma Editorial

Chromosomal instability and acquired drug resistance in multiple myeloma Review

A novel Fc-engineered human ICAM-1/CD54 antibody with potent anti-myeloma activity developed by cellular panning of phage display libraries Research Paper

Chondroitin sulfate proteoglycan serglycin influences protein cargo loading and functions of tumor-derived exosomes Research Paper

Glutaminase inhibition in multiple myeloma induces apoptosis via MYC degradation Research Paper

Lenalidomide overcomes the immunosuppression of regulatory CD8⁺CD28^â€“ T-cells Research Paper